Latest Hemophilia news
Efanesoctocog Alfa Prophylaxis Beneficial for Children With Hemophilia A
posted July 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
ISTH Issues Clinical Practice Guideline for the Treatment of Hemophilia
posted July 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Once-Weekly Efanesoctocog Alfa Beneficial in Severe Hemophilia A
posted January 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First Gene Therapy for Adults With Hemophilia B
posted November 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Suspends U.S. License of Chikungunya Vaccine 
Efanesoctocog Alfa Not Cost-Effective for Prophylaxis in Hemophilia A 
Fidanacogene Elaparvovec Superior to Prophylaxis for Hemophilia B 
Valoctocogene Roxaparvovec Evaluated in Severe Hemophilia A 
AAV Gene Transfer Feasible for the Treatment of Hemophilia A Monthly Specialist Briefings
Stay Connected
